Literature DB >> 20562119

Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality.

H M Lee1, H Le, B T Lee, V A Lopez, N D Wong.   

Abstract

Forced vital capacity (FVC) measures lung function and predicts coronary heart disease (CHD); whether it provides additive prediction over CHD risk factors has not been established. We examined whether FVC adds to the prediction of all-cause mortality provided by Framingham Risk Score (FRS) alone. We examined 5,485 (61.1 million projected) nonsmoking adults from the USA who were aged 20-79 yrs. Subjects were from the Third National Health and Nutrition Examination Survey, were without obstructive lung disease, had FVC measurements and had ≤ 12 yrs (mean 8.8 yrs) mortality follow-up. We performed Cox regression analysis to examine whether FVC and forced expiratory volume in 1 s (FEV(1)) (categorised as low ≤ 85% predicted, borderline 86-94% predicted and normal ≥ 95% predicted) within FRS groups (10-yr risk of cardiovascular disease low <10%, intermediate 10-20%, high 20%) predict mortality. Receiver operator characteristic analysis examined whether FVC and FEV(1) added to the prediction provided by FRS. Low-, intermediate- and high-risk FRS groups had 79.5% (n = 4,361), 10.1% (n = 555) and 10.4% (n = 569) persons, respectively. Only the intermediate FRS group showed a graded increase in mortality (10.7, 18.2 and 42.8% per 1,000 person-yrs from highest to lowest FVC categories, respectively); those with low FVC had an almost three-fold greater risk of mortality (hazard ratio 2.64; p<0.01) than those with normal FVC. FVC provided incremental additive value for predicting mortality in addition to FRS for only this group (area under curve 0.65 versus 0.58; p<0.05). Similar results were obtained for FEV(1). Evaluation of lung function may be useful to improve risk stratification in persons with intermediate CHD risk where it adds to prediction of mortality over global risk assessment.

Entities:  

Mesh:

Year:  2010        PMID: 20562119     DOI: 10.1183/09031936.00042410

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  46 in total

1.  Decreased Lung Function and All-Cause Mortality in HIV-infected Individuals.

Authors:  Matthew R Gingo; Mehdi Nouraie; Cathy J Kessinger; Ruth M Greenblatt; Laurence Huang; Eric C Kleerup; Lawrence Kingsley; Deborah K McMahon; Alison Morris
Journal:  Ann Am Thorac Soc       Date:  2018-02

2.  Effect of traditional aerobic exercises versus sprint interval training on pulmonary function tests in young sedentary males: a randomised controlled trial.

Authors:  Badaam Khaled M; Munibuddin A; Khan S T; Choudhari S P; Doiphode R
Journal:  J Clin Diagn Res       Date:  2013-09-10

3.  Impact of lung-function measures on cardiovascular disease events in older adults with metabolic syndrome and diabetes.

Authors:  Hwa Mu Lee; Yanglu Zhao; Michael A Liu; David Yanez; Mercedes Carnethon; R Graham Barr; Nathan D Wong
Journal:  Clin Cardiol       Date:  2018-07-17       Impact factor: 2.882

Review 4.  The Effect of Ancestry and Genetic Variation on Lung Function Predictions: What Is "Normal" Lung Function in Diverse Human Populations?

Authors:  Victor E Ortega; Rajesh Kumar
Journal:  Curr Allergy Asthma Rep       Date:  2015-04       Impact factor: 4.806

5.  Spirometry, Static Lung Volumes, and Diffusing Capacity.

Authors:  Carlos A Vaz Fragoso; Hilary C Cain; Richard Casaburi; Patty J Lee; Lynne Iannone; Linda S Leo-Summers; Peter H Van Ness
Journal:  Respir Care       Date:  2017-07-11       Impact factor: 2.258

6.  Comment on: Wollmer P, Engström G. Fixed ratio or lower limit of normal (LLN) as cut-off value for FEV1/VC: An outcome study. Respiratory Medicine (2013) 107, 1460-1462.: Fixed ratio or lower limit of normal (LLN) as cut-off value for FEV1/VC.

Authors:  Carlos A Vaz Fragoso; Jeffrey J Pretto; Philip H Quanjer
Journal:  Respir Med       Date:  2015-05-02       Impact factor: 3.415

7.  Respiratory impairment and COPD hospitalisation in older persons: a competing risk analysis.

Authors:  Carlos A Vaz Fragoso; John Concato; Gail McAvay; Peter H Van Ness; Thomas M Gill
Journal:  Eur Respir J       Date:  2012-01-20       Impact factor: 16.671

8.  Environmental exposures and systemic hypertension are risk factors for decline in lung function.

Authors:  Catherine H Miele; Matthew R Grigsby; Trishul Siddharthan; Robert H Gilman; J Jaime Miranda; Antonio Bernabe-Ortiz; Robert A Wise; William Checkley
Journal:  Thorax       Date:  2018-07-30       Impact factor: 9.139

9.  Forced vital capacity predicts long-term survival for curative-resected NSCLC.

Authors:  Xi Guo; Hongxin Cao; Jun Xu; Jianyu Yu; Chunlong Zheng; Long Meng; Jiajun Du
Journal:  Med Oncol       Date:  2014-08-07       Impact factor: 3.064

10.  Asthma and lung structure on computed tomography: the Multi-Ethnic Study of Atherosclerosis Lung Study.

Authors:  Kathleen M Donohue; Eric A Hoffman; Heather Baumhauer; Junfeng Guo; Firas S Ahmed; Gina S Lovasi; David R Jacobs; Paul Enright; R Graham Barr
Journal:  J Allergy Clin Immunol       Date:  2013-02       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.